Drug Testing Locations - Montrose, CO

Drug Testing in Montrose, CO

Montrose, Colorado Statistics

In 2020, Montrose County had a fentanyl-related overdose rate of 15.6 per 100,000 residents.

Montrose, CO, reported 78 emergency room visits related to opioid abuse in 2021.

In Montrose County, methamphetamine was involved in 42% of all drug-related arrests in 2022.

Alcohol-related offenses accounted for 35% of all substance abuse arrests in Montrose, CO in 2021.

Montrose County saw a 12% increase in drug-related hospital admissions from 2019 to 2020.

In a 2022 survey, 18% of Montrose High School students reported having used marijuana in the past month.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Montrose, CO & Drug Testing Policies

Employers in Montrose, CO, are increasingly adopting strict drug testing policies to maintain a safe and productive work environment. Many companies follow guidelines from the Colorado Department of Labor and Employment, ensuring compliance with state regulations.

Some businesses in Montrose have gone beyond random drug testing, implementing ongoing employee education on substance abuse. The aim is to create awareness about the risks associated with drug use, thereby promoting a healthier workforce.

Government Efforts with Drug Problems in Montrose, CO

Montrose, CO, has been actively working to combat drug issues through several government initiatives. The City collaborates with the Colorado Department of Human Services to enhance public health interventions and provide resources for mental health and substance abuse services.

The Montrose County Sheriff's Office has increased the number of educational programs targeted at schools to prevent drug abuse among youth. Additionally, there is cooperation with the Montrose County Human Services for community outreach and rehabilitation programs.

Local Drug Busts & News in Montrose, CO

Local law enforcement in Montrose, CO, has made large strides in its fight against drug trafficking. In 2022, a significant drug bust led to the seizure of over 300 pounds of illegal drugs, including meth and cocaine, in Montrose County.

The Montrose Police Department regularly holds press conferences to inform the community about recent seizures and arrests, such as the notable heroin ring takedown in early 2023. These operations highlight the ongoing efforts to curb drug-related activities in the area.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Montrose, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Drug-Free Montrose

Colorado Health Information

Colorado Dept. of Human Services Behavioral Health

Montrose Health

Colorado Dept. of Labor and Employment

Montrose County Human Services

Mental Health Partners

SAMHSA

Drug Testing Near Montrose, CO

Paonia, CO

Cedaredge, CO

Delta, CO

Orchard City, CO

Hotchkiss, CO

Ridgway, CO

Ouray, CO

Lazear, CO

Crawford, CO

Loghill Village, CO

Colona, CO

Olathe, CO

Frequently Asked Questions

Customer Reviews